Table 1. In vitro anti-tumor activity of IMB-1406 and sunitinib against four cell lines.
Cell lines | Inhibition rate (30 μM) | IC50 (μM) | ||
---|---|---|---|---|
IMB-1406 | Sunitinib | IMB-1406 | Sunitinib | |
A549 | 100.07% | 100.02% | 8.99 | 10.36 |
HepG2 | 99.98% | 98.61% | 6.92 | 7.60 |
DU145 | 99.93% | 86.51% | 7.89 | 7.99 |
MCF7 | 100.39% | 88.89% | 8.26 | 8.65 |